Attune Neurosciences key facts
- Developer of neurostimulation products designed to improve human health and performance.
- It has raised $6.8M; the latest was Accelerator/Incubator in Feb 2025.
- Notable investors include National Institutes of Health, Joyance Partners, One Mind, Prime Movers Lab, Satori Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·Watch Attune Neurosciences: the Monday email on marks, rounds and moves
Attune Neurosciences funding rounds
No funding rounds for Attune Neurosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Attune Neurosciences investors
7 investors are on record for Attune Neurosciences, including National Institutes of Health, Joyance Partners, One Mind and Prime Movers Lab.
About Attune Neurosciences
Developer of neurostimulation products designed to improve human health and performance. The company's products target sleep-related conditions that modulate the activity of the brain structures, enabling patients to improve symptoms of central nervous system disorders for patients.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2019
- Employees
- 22
- Website
- attuneneuro.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Attune Neurosciences doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.